140 related articles for article (PubMed ID: 25419240)
21. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
[TBL] [Abstract][Full Text] [Related]
22. Visual Inspection with Acetic Acid (VIA) Screening Program: 7 Years Experience in Early Detection of Cervical Cancer and Pre-Cancers in Rural South India.
Poli UR; Bidinger PD; Gowrishankar S
Indian J Community Med; 2015; 40(3):203-7. PubMed ID: 26170547
[TBL] [Abstract][Full Text] [Related]
23. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
24. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
25. High-risk human papilloma virus and cervical abnormalities in HIV-infected women with normal cervical cytology.
Musa J; Achenbach C; Taiwo B; Berzins B; Silas O; Daru PH; Agbaji O; Imade G; Sagay AS; Idoko JA; Kanki PJ; Murphy RL
Infect Agent Cancer; 2014; 9(1):36. PubMed ID: 25395987
[TBL] [Abstract][Full Text] [Related]
26. Benefits of HIV screening of blood transfusions in Zambia.
Foster S; Buvé A
Lancet; 1995 Jul; 346(8969):225-7. PubMed ID: 7616804
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.
Reynales-Shigematsu LM; Rodrigues ER; Lazcano-Ponce E
Arch Med Res; 2009 Aug; 40(6):503-13. PubMed ID: 19853192
[TBL] [Abstract][Full Text] [Related]
28. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
[TBL] [Abstract][Full Text] [Related]
29. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
Omenge Orang'o E; Liu T; Christoffersen-Deb A; Itsura P; Oguda J; Washington S; Chumba D; Pisharodi L; Cu-Uvin S; Rositch AF
AIDS; 2017 Jan; 31(2):233-240. PubMed ID: 28002084
[TBL] [Abstract][Full Text] [Related]
30. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
Lawson HW; Henson R; Bobo JK; Kaeser MK
MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
[TBL] [Abstract][Full Text] [Related]
31. Sexual and reproductive health and HIV services: integrating HIV/AIDS and cervical cancer prevention and control.
Belhadj H; Rasanathan JJ; Denny L; Broutet N
Int J Gynaecol Obstet; 2013 May; 121 Suppl 1():S29-34. PubMed ID: 23477703
[TBL] [Abstract][Full Text] [Related]
32. The use of thermal ablation in diverse cervical cancer "screen-and-treat" service platforms in Zambia.
Mwanahamuntu M; Kapambwe S; Pinder LF; Matambo J; Chirwa S; Chisele S; Basu P; Prendiville W; Sankaranarayanan R; Parham GP
Int J Gynaecol Obstet; 2022 Apr; 157(1):85-89. PubMed ID: 34197624
[TBL] [Abstract][Full Text] [Related]
33. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia.
Mwanahamuntu MH; Sahasrabuddhe VV; Kapambwe S; Pfaendler KS; Chibwesha C; Mkumba G; Mudenda V; Hicks ML; Vermund SH; Stringer JS; Parham GP
PLoS Med; 2011 May; 8(5):e1001032. PubMed ID: 21610859
[TBL] [Abstract][Full Text] [Related]
34. Cervical cancer prevention program in Jakarta, Indonesia: See and Treat model in developing country.
Nuranna L; Aziz MF; Cornain S; Purwoto G; Purbadi S; Budiningsih S; Siregar B; Peters AA
J Gynecol Oncol; 2012 Jul; 23(3):147-52. PubMed ID: 22808356
[TBL] [Abstract][Full Text] [Related]
35. Digital cervicography for cervical cancer screening in low-resource settings: A scoping review.
Chongsuwat T; Wang C; Sohn Y; Klump K
Gynecol Oncol Rep; 2023 Feb; 45():101130. PubMed ID: 36683777
[TBL] [Abstract][Full Text] [Related]
36. Monitoring the performance of "screen-and-treat" cervical cancer prevention programs.
Mwanahamuntu MH; Sahasrabuddhe VV; Blevins M; Kapambwe S; Shepherd BE; Chibwesha C; Pfaendler KS; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Stringer JSA; Parham GP
Int J Gynaecol Obstet; 2014 Jul; 126(1):88-89. PubMed ID: 24810795
[No Abstract] [Full Text] [Related]
37. Factors Associated with Treatment Uptake Among Women with Acetic Acid/Lugol's Iodine Positive Lesions of the Cervix in Cameroon.
Manga SM; Shi L; Welty TK; DeMarco RF; Aronowitz T
Int J Womens Health; 2020; 12():495-504. PubMed ID: 32612397
[TBL] [Abstract][Full Text] [Related]
38. Zambia cervical cancer control program resource mapping - Leveraging support to achieve the 90-70-90 elimination target.
Lombe D; Msadabwe S; Maka M; Samboko M; Haimbe P; Sichamba S; Chanda D; Choobe N; Banda P; Simwenda M; Chaila MJ; Kamfwa P; Soko U; Lishimpi K; Kapambwe S
J Cancer Policy; 2021 Jun; 28():100281. PubMed ID: 35559910
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
